covidien

Covidien has obtained US Food and Drug Administration (FDA) 510(k) clearance for its Puritan Bennett 980 ventilator, the new acute care ventilator that delivers advanced breath technology for patients comfort and ease-of-use for clinicians.

By using new advanced synchrony tools, the Puritan Bennett 980 ventilator helps clinicians set the ventilator to adapt to their patients’ unique needs and provide the appropriate level of support throughout the breath.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The Puritan Bennett 980 ventilator system is designed for patients ranging from neonatal to adult.

It offers a range of software capabilities, including proportional assist ventilation plus (PAV) and leak sync software.

PAV software for the Puritan Bennett 980 ventilator is a breath type that better manages work of breathing in spontaneously breathing patients and promotes natural breathing compared with conventional mechanical ventilation.

According to the company, this software has been shown to help reduce asynchrony, which studies have shown may reduce days on mechanical ventilation.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

With its range of software capabilities, the new ventilator system helps clinicians to get patients off mechanical ventilation as soon as possible.

Covidien respiratory solutions vice-president and general manager James E Willett said: "The Puritan Bennett 980 ventilator provides clinicians with a simple, safe and smart way to care for patients."

The company expects to launch the ventilator system in Japan and Canada, where it was earlier approved for commercial distribution, along with the US in the coming months.

According to GlobalData estimates, the US ventilators market was valued at $163.9m in 2012 and is expected to grow at a CAGR of 3.4% to reach $206.4m by 2019.

Image: Puritan Bennett 980 ventilator gets FDA clearance. Photo: courtesy of Covidien/Business Wire.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact